Total Payments
$7,128
2024 Payments
$693.19
Companies
38
Transactions
305
Medicare Patients
6,080
Medicare Billing
$515,316
Payment Breakdown by Category
Food & Beverage$7,038 (98.7%)
Education$89.99 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,038 | 304 | 98.7% |
| Education | $89.99 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,017 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $722.57 | 45 | $0 (2023) |
| HEARTFLOW, INC. | $710.20 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $707.09 | 38 | $0 (2024) |
| PFIZER INC. | $626.47 | 33 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $294.12 | 19 | $0 (2023) |
| Amgen Inc. | $265.70 | 14 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $246.35 | 15 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $216.55 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $195.25 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $693.19 | 28 | PFIZER INC. ($147.48) |
| 2023 | $1,011 | 45 | PFIZER INC. ($225.23) |
| 2022 | $1,548 | 61 | Janssen Pharmaceuticals, Inc ($210.96) |
| 2021 | $1,146 | 51 | HeartFlow, Inc. ($311.20) |
| 2020 | $653.22 | 26 | Abbott Laboratories ($152.99) |
| 2019 | $739.08 | 36 | Abbott Laboratories ($165.06) |
| 2018 | $557.41 | 29 | Abbott Laboratories ($163.45) |
| 2017 | $779.79 | 29 | Abbott Laboratories ($330.51) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $106.30 | General |
| Category: Coronary | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.51 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/03/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $66.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Heart Failure | ||||||
| 03/01/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: NEUROLOGY | ||||||
| 02/28/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/22/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/22/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/08/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/06/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,576 | 1,938 | $471,903 | $121,851 |
| 2022 | 24 | 1,553 | 1,947 | $493,001 | $125,351 |
| 2021 | 22 | 1,427 | 1,872 | $535,204 | $133,408 |
| 2020 | 24 | 1,524 | 2,031 | $561,630 | $134,706 |
Total Patients
6,080
Total Services
7,788
Medicare Billing
$515,316
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 293 | 452 | $67,800 | $27,659 | 40.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 130 | 130 | $104,000 | $17,906 | 17.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 176 | $26,400 | $10,343 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 105 | $23,100 | $10,178 | 44.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 21 | 21 | $52,500 | $7,143 | 13.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 54 | 54 | $27,540 | $6,921 | 25.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 64 | 66 | $18,480 | $6,453 | 34.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 124 | 125 | $31,150 | $6,122 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 330 | 359 | $16,873 | $3,658 | 21.7% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 34 | 34 | $8,330 | $3,042 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,705 | $2,658 | 34.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 14 | 56 | $8,400 | $2,468 | 29.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 13 | 13 | $10,400 | $2,252 | 21.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $6,380 | $2,110 | 33.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 22 | $5,500 | $2,052 | 37.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 49 | 55 | $4,950 | $1,954 | 39.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 26 | 46 | $3,680 | $1,708 | 46.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 19 | 20 | $5,500 | $1,609 | 29.2% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 22 | 23 | $18,400 | $1,554 | 8.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 26 | 26 | $4,940 | $1,294 | 26.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $2,665 | $842.66 | 31.6% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 22 | 22 | $8,800 | $708.00 | 8.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 13 | 13 | $4,810 | $625.97 | 13.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 19 | 20 | $1,200 | $278.00 | 23.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 15 | 15 | $1,200 | $263.58 | 22.0% |
About Dr. Arjun Nair, M.D
Dr. Arjun Nair, M.D is a Nuclear Cardiology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1982866968.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arjun Nair, M.D has received a total of $7,128 in payments from pharmaceutical and medical device companies, with $693.19 received in 2024. These payments were reported across 305 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($7,038).
As a Medicare-enrolled provider, Nair has provided services to 6,080 Medicare beneficiaries, totaling 7,788 services with total Medicare billing of $515,316. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease
- Location Plano, TX
- Active Since 06/30/2008
- Last Updated 05/18/2023
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1982866968
Products in Payments
- ELIQUIS (Drug) $848.24
- XARELTO (Drug) $722.57
- FFRct (Device) $625.55
- ENTRESTO (Drug) $573.44
- Confirm Rx (Device) $305.98
- MRI Ready Leads (Device) $302.51
- LifeVest (Device) $216.55
- Repatha (Biological) $185.03
- Vascepa (Drug) $182.10
- JOT DX (Device) $164.68
- Quadra Assura CRT Defibrillator (Device) $156.54
- BRILINTA (Drug) $149.58
- ONYX FRONTIER (Device) $141.59
- LEQVIO (Drug) $133.65
- MULTAQ (Drug) $132.42
- Flexitouch Plus (Device) $128.73
- NEXLETOL (Drug) $127.08
- PRALUENT (Drug) $113.93
- VERQUVO (Drug) $106.49
- BYSTOLIC (Drug) $100.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Cardiology Doctors in Plano
Dr. Rikesh Patel, M.d, M.D
Nuclear Cardiology — Payments: $36,124
Nuclear Cardiology $36,124
Timothy Dao, M.d, M.D
Nuclear Cardiology — Payments: $31,214
Nuclear Cardiology $31,214
Dr. Marc Pieniek, Md, MD
Nuclear Cardiology — Payments: $18,859
Nuclear Cardiology $18,859
Dr. John Duncan, Md, MD
Nuclear Cardiology — Payments: $15,967
Nuclear Cardiology $15,967
Dr. Amir Choudhry, M.d, M.D
Nuclear Cardiology — Payments: $11,717
Nuclear Cardiology $11,717